Carlyle Group Inc (CG) 2026 Annual Meeting

BA BRIEFING·
Carlyle Group Inc (CG) 2026 Annual Meeting
13 directors up · 12 in watch zone · 4 proposals · Uncontested
$16.2B mkt cap · 1Y TSR +0.3% · Board C+
Director Elections (13) · 13 of 13 scored by BA forecast
Election Outlook
Most directors look set to be re-elected without meaningful dissent — 1 of 13 scored nominees are rated Healthy. 12 are flagged for elevated vote pressure; the most-loaded are Lawton W. Fitt (prior 93.7%, forecast Material), Mark S. Ordan (prior 98.1%, forecast Elevated), and Anthony Welters (prior 95.3%, forecast Elevated), with 9 other(s) in the table below.
NomineeForecastBackground
Not independent
WATCH
Prior 96.8%
70808793100
Co-founder and Co-Chairman of Carlyle since 1987, contributing to its growth and strategic direction.
Not independent
WATCH
Prior 97.4%
70808793100
Co-founder and Co-Chairman of Carlyle since 1987, instrumental in the firm's growth and strategic direction.
Not independent
WATCH
Prior 97.5%
70808793100
Co-founder and Chairman Emeritus of Carlyle, integral to its growth since 1987.
Not independent
HEALTHY
Prior 98.8%
70808793100
Chief Executive Officer and Director since 2023, with extensive leadership experience at global financial institutions.
Afsaneh Beschloss
Independent
WATCH
First-time at this board · prior vote history at other boards
Independent
WATCH
Prior 98.8%
70808793100
Senior partner at EY with extensive experience in private equity, financial services, and health care industries.
Independent
ELEVATED
Prior 94.8%
70808793100
Linda H. Filler has served as a lead independent director at large, global businesses.
Independent
MATERIAL
Prior 93.7%
70808793100
Fitt has an extensive financial services background with a distinguished career at Goldman Sachs in investment banking and risk analysis.
Not independent
ELEVATED
Prior 93.7%
70808793100
Former Chief Financial Officer of Bank of America Corporation and Operating Executive at Carlyle.
Independent
ELEVATED
Prior 98.1%
70808793100
Mark S. Ordan has served as CEO of multiple companies and is currently the Lead Independent Director since 2022.
Independent
ELEVATED
Prior 95.3%
70808793100
Derica W. Rice has extensive experience in global business operations and financial matters from his career at CVS Health and Eli Lilly and Company.
Independent
WATCH
Prior 94.6%
70808793100
William J. Shaw has extensive financial and management experience from senior leadership roles at Marriott.
Independent
ELEVATED
Prior 95.3%
70808793100
Welters founded AmeriChoice, which was acquired by UnitedHealth Group in 2002, and served as Senior Adviser to the Office of the CEO until retiring in 2016.
Proposals on the Ballot (4)
#1
Election of Directors
Filed by the board · Board recommends For
Election of 13 director nominees named in the proxy statement to serve one‑year terms until the next annual meeting.
#2
Ratification of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2026
Filed by the board · Board recommends For
Ratify the Audit Committee’s selection of Ernst & Young LLP as Carlyle’s independent registered public accounting firm for fiscal year 2026.
#3
Approval of The Carlyle Group Inc. Amended and Restated 2012 Equity Incentive Plan
Filed by the board · Board recommends For
Approve the Amended and Restated 2012 Equity Incentive Plan to increase the share reserve by 19,000,000 shares, extend the plan term, and allow recycling of withheld shares for tax withholding.
Detail ›
This management proposal seeks shareholder approval for an amendment and restatement of the existing 2012 Equity Incentive Plan, primarily to increase the authorized share reserve by 19 million shares (from 58.8 million to 77.8 million), extend the plan term to , and permit recycling of withheld shares used for tax withholding (excluding options and SARs). Management and the Compensation Committee justify the request by saying additional capacity is necessary to continue granting equity awards that align employee incentives with shareholder interests, to retain and incentivize senior personnel and support Firm strategic objectives and multi-year targets through 2028. The proposal outlines plan mechanics including counting rules for share usage, minimum vesting requirements (one year vesting cliff for most awards with limited exceptions), per-participant and non-employee director limits, and detailed adjustment and change-in-control provisions. The plan contains customary tax and administrative provisions (including compliance with Section 409A) and describes the Company’s existing equity program usage, the number of outstanding RSUs and PSUs, and projected available shares post-approval. The Board recommends a “FOR” vote emphasizing careful monitoring of dilution, linking awards to performance via PSUs and retention via time-vesting RSUs, and plans to manage share usage alongside its $2 billion repurchase program. Key risks include shareholder dilution and the potential for large equity grants to executives, but management points to historical and prospective practices (bonus deferral, clawbacks, stock ownership guidelines, and retention/vesting constraints) intended to mitigate those concerns.
#4
Non-Binding Vote to Approve Named Executive Officer Compensation (“Say-on-Pay”
Filed by the board · Board recommends For
Advisory, non-binding vote to approve the compensation of the named executive officers as disclosed in the proxy statement.
Detail ›
This advisory management proposal asks shareholders to approve, on a non-binding basis, the compensation paid to the named executive officers as disclosed in the proxy statement, including the CD&A and compensation tables. The Board and Compensation Committee promote a pay-for-performance philosophy, with significant equity-based compensation (RSUs, PSUs, bonus deferral, and carried interest arrangements) tying management incentives to long-term firm performance. The CD&A describes program elements including the CEO’s sign-on PSUs with absolute stock price and relative TSR hurdles, the Stock Price Appreciation PSU Program for other NEOs, execution of a Bonus Deferral Program to increase RSU deferrals, executive stock ownership guidelines, clawback policies, and restrictions on hedging/pledging. Management argues that recent strong TSR (119% 3-year) and record 2025 financial results support the program’s efficacy and alignment. The recommendation to vote FOR is accompanied by a commitment to consider shareholder feedback in future compensation decisions; however, risks include potential dilution from equity awards and complexity of incentive structures which some shareholders may view skeptically.
Top institutional holders · as of Mar 31, 2026
Holder% of sharesPosition value
Capital World Investors4.95%$863M
HARRIS ASSOCIATES L P4.51%$786M
BlackRock, Inc.3.79%$661M
VANGUARD PORTFOLIO MANAGEMENT LLC3.28%$572M
VANGUARD CAPITAL MANAGEMENT LLC3.17%$551M
STATE STREET CORP2.69%$468M
BlackRock, Inc.2.31%$402M
MILLENNIUM MANAGEMENT LLC1.89%$329M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC1.75%$305M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1.65%$287M
Source: SEC 13F filings (latest quarter). Position value is the holder’s reported aggregate value at the as-of date.
Recent key filings
Quarterly report (10-Q)View ›
Definitive proxy (DEF 14A)View ›
Annual report (10-K)View ›
Quarterly report (10-Q)View ›
Quarterly report (10-Q)View ›
Definitive proxy (DEF 14A)View ›
About the risk forecast

The risk forecast scores each director on the company’s slate against Boardroom Alpha’s YoY Director-Vote Forecast model — three XGBoost classifiers that estimate the probability the director’s vote support falls below 70%, 80%, and 90% at the upcoming annual meeting, augmented by a five-rule governance escalation layer (overboarding, audit-committee composition, prior dissent, and others).

Bands map to those probability thresholds:

  • Crisis — high probability of vote support below 70%. Rare.
  • Material — high probability of below 80%. The primary screening threshold.
  • Elevated — significant elevated risk of dissent.
  • Watch — even a mild withhold is detectable. Informational.
  • Healthy — no signal of meaningful dissent.

Prior is the director’s most-recent vote-support percentage at this same board. Direction compares the forecast to that prior vote: ↑ expected better means more support than last year; ↓ expected worse means less.

Forecast applies only to non-contested annual proxies (DEF 14A). Contested situations are tracked separately on the contested-proxy pipeline. The model is retrained nightly; bands shown reflect the most recent run.

« Back to Shareholder Meeting Calendar

Get this in your inbox
Activism and governance research, in your inbox
Director nominee slates, proposals, settlement campaigns, and AGM outcomes from US public companies.

Frequently Asked Questions

When is the Carlyle Group Inc 2026 annual meeting?
Carlyle Group Inc (CG) holds its 2026 annual shareholder meeting on June 3, 2026.
What is the record date for the Carlyle Group Inc 2026 meeting?
The record date for the Carlyle Group Inc 2026 meeting is April 6, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Carlyle Group Inc's 2026 meeting?
The board is presenting 13 director nominees at the Carlyle Group Inc 2026 meeting. The full slate appears in the 'Director Nominees' table on this page, with independence designations and a structured indexable summary.
What proposals will shareholders vote on at the Carlyle Group Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Carlyle Group Inc 2026 meeting. The full list with proposed-by tags and management recommendations appears in the 'Proposals on the Ballot' section on this page.
Are any directors at risk at Carlyle Group Inc's 2026 annual meeting?
The Boardroom Alpha Director-Vote Forecast flags 12 of 13 scored nominees as facing elevated vote pressure at the Carlyle Group Inc 2026 meeting: William E. Conway, Jr., David M. Rubenstein, Daniel A. D’Aniello, Afsaneh Beschloss, Sharda Cherwoo plus 7 other(s). The most-loaded nominee is Lawton W. Fitt (forecast band: material). Prior support: 93.7%. See the 'Director Nominees' table for the per-director forecast bar and prior support.
Where do I find the original proxy filing?
The 'View proxy' link at the top of this page opens the original SEC DEF 14A (or amended) filing for the Carlyle Group Inc 2026 meeting in the Boardroom Alpha filing viewer.

Last updated: